Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy

Kidney Int. 2024 Jun;105(6):1320. doi: 10.1016/j.kint.2024.03.007.
No abstract available

Publication types

  • Letter

MeSH terms

  • Autoantibodies* / blood
  • Autoantibodies* / immunology
  • Cell- and Tissue-Based Therapy / methods
  • Glomerulonephritis, Membranous* / immunology
  • Glomerulonephritis, Membranous* / therapy
  • Humans
  • Male
  • Receptors, Chimeric Antigen / immunology
  • Treatment Outcome

Substances

  • Autoantibodies
  • Receptors, Chimeric Antigen